BridgeMD
New treatment option for Scarring Alopecia
Official title Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
ClinicalTrials.gov ID: NCT06946550
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the effectiveness of a non-ablative 1470 nm laser in treating scarring alopecia in adults. The study will also investigate the biochemical molecular pathways involved in laser therapy by analyzing hair follicle gene expression before and after laser treatment.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Healthy males and females, at least 18 years of age at time of informed consent, seeking treatment for scarring alopecia
- Subject must be able to read, understand, and voluntarily sign and date an IRB-approved informed consent form
- people with biopsy-proven or clinically diagnosed scarring alopecia recorded within the past 6 months. An established clinical diagnosis will be...
- Subject agrees to not make any changes to their daily hair treatment regimen or start any medications for hair loss such as minoxidil during the...
- people able and willing to comply with the treatment protocol and follow-up schedule and requirements.
You likely can't join if
- Subject does not have capacity to consent to the study
- No ethnic or racial group restrictions
- Subject does not have scarring alopecia
- History of intralesional steroid injections to the scalp in the last 12 months
- Pregnant Women
- Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject.
See the full eligibility criteria
- Healthy males and females, at least 18 years of age at time of informed consent, seeking treatment for scarring alopecia
- Subject must be able to read, understand, and voluntarily sign and date an IRB-approved informed consent form
- people with biopsy-proven or clinically diagnosed scarring alopecia recorded within the past 6 months. An established clinical diagnosis will be confirmed by a licensed dermatologist as in previously published hair...
- Subject agrees to not make any changes to their daily hair treatment regimen or start any medications for hair loss such as minoxidil during the study.
- people able and willing to comply with the treatment protocol and follow-up schedule and requirements.
- Understands and accepts the obligation not to undergo any other procedures in the areas to be treated throughout the follow-up period.
- Subject does not have capacity to consent to the study
- No ethnic or racial group restrictions
- Subject does not have scarring alopecia
- History of intralesional steroid injections to the scalp in the last 12 months
- Pregnant Women
- Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject.
- Any previous hospitalization or surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months.
- Allergy or history of prior reaction to lidocaine
- History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy in the prior 12 months.
- Recent COVID-19 infection
- History or current use of the following prescription medications:
- Immunosuppressive medications/biologics, 6 months prior to and during the study
- Accutane or other systemic retinoids within the past twelve months
- Smoking or vaping in the past 12 months.
- History of uncontrolled hyperlipidemia, uncontrolled diabetes mellitus, uncontrolled hepatitis, or uncontrolled bleeding disorders.
- History of major depressive disorders or uncontrolled endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism.
The study team makes the final eligibility decision.
Where it's taking place
- Elmsford, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Elmsford, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.